Bharat Book Bureau Provides the Trending Market Research Report on “Global Haemophilia Treatment Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026”under Life Sciences Market Science Report Category. The report offers a collection of superior market research, market analysis, analysis, competitive intelligence and Market reports.
Global Haemophilia Treatment Market was valued at USD13906.45 million in 2020 and is forecast to reach USD24205.39 million in 2026 by registering a CAGR of 9.06% during the forecast period. The global haemophilia treatment market is driven by increasing awareness campaigns regarding haemophilia among the population across the globe. Moreover, ongoing attempts in research and development activities for the development of new therapy solutions is positively impacting the growth of the market. Also, surging incidences of bleeding disorders have been observed worldwide, which is further expected to bolster the growth of market over the next few years.
The global haemophilia treatment market is segmented based on type, product, treatment, therapy, company and region. Based on type, the market can be categorized into Haemophilia A, Haemophilia B and Haemophilia C. Generally, the classification depends on the deficiency of coagulation factor present in a patient. Based on that, type A is the most frequent type, and the prevalence rate has been recorded to be four times more than haemophilia type B. In addition to this, majority of existing products are used for treating type A haemophilia, which is contributing to the increasing growth of the segment over the coming years.
Regionally, the market is segregated into North America, Europe, Asia- Pacific, South America and Middle East and Africa.
Out of which, North America dominated the global haemophilia treatment market in 2020 owing to increased prevalence of haemophilia A & B in the United States and Canada. Besides this, organic and inorganic strategies of major pharmaceutical companies present in the United States is further contributing to the market growth in the region. Additionally, Asia Pacific region is expected to grow at the fastest rate in the coming years. This high growth can be ascribed to the ease of regulatory policies in Australia and Japan for the approval of drugs for the treatment of haemophilia A. In addition to this, improved funding by public and private players for the improvisation of healthcare facilities in India and China, is further anticipated the drive the market growth in Asia Pacific.
Major players operating in the global haemophilia treatment market include Novo Nordisk A/S, F. Hoffmann-La Roche AG, Bayer AG, Pfizer, Inc., Takeda Pharmaceutical Company, Sanofi S.A., CSL Behring LLC, BioMarin Pharmaceutical Inc., Octapharma AG, Sangamo Therapeutics Inc., Eagle Pharmaceuticals Inc., Baxter International, Inc., Grifols SA, Biogen Idec, Inc., Alnylam Pharmaceuticals Inc., and others. The companies are adopting new strategies in order to stay competitive in the market. Rising competitiveness is anticipated to drive innovation in the market, therefore helping the industry to solve existing challenges and meet the unmet needs in the market. Besides, these major market players are focusing on new product development, mergers and acquisitions, and business expansion to attain a higher market share.
Years considered for this report:
Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022–2026
Objective of the Study:
•To analyze the historical growth in the market size of global haemophilia treatment market from 2016 to 2020.
•To estimate and forecast the market size of global haemophilia treatment market from 2021 to 2026 and growth rate until 2026.
•To classify and forecast global haemophilia treatment market based on type, product, treatment, therapy, company and regional distribution.
•To identify dominant region or segment in the global haemophilia treatment market.
•To identify drivers and challenges for global haemophilia treatment market.
•To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global haemophilia treatment market.
•To conduct pricing analysis for global haemophilia treatment market.
•To identify and analyze the profile of leading players operating in global haemophilia treatment market.
•To identify key sustainable strategies adopted by market players in global haemophilia treatment market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/labs and presence of all major players across the globe.
TechSci Research calculated the market size of global haemophilia treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
•Haemophilia treatment facilities, companies and other stakeholders
•Government bodies such as regulating authorities and policy makers
•Organizations, forums and alliances related to haemophilia treatment
•Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, global haemophilia treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Global Haemophilia Treatment Market, By Type:
•Global Haemophilia Treatment Market, By Product:
-Recombinant Coagulation Factor Concentrates
-Plasma Derived Coagulation Factor Concentrate
•Global Haemophilia Treatment Market, By Treatment:
•Global Haemophilia Treatment Market, By End-user:
•Global Haemophilia Treatment Market, By Region:
-Middle East & Africa
Company Profiles: Detailed analysis of the major companies present in global haemophilia treatment market.
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
•Detailed analysis and profiling of additional market players (up to five)
Browse our full report with Table of Content :
About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]